models of Alzheimer's disease (AD), cognitive dysfunction of atherosclerosis, and normative aging. Genetic reduction of TORC1 in neurons to levels similar to those achieved by rapamycin, promoted synaptic bouton remodeling, enhanced memory, and increased brain glucose metabolism. In AD mice, the restoration of CBF and neurovascular coupling by mTOR attenuation was dependent on the activation of both constitutive nitric oxide synthase (NOS) isoforms, possibly due to stabilization of their mRNAs. The mechanisms by which mTOR attenuation preserves brain healthspan may be common to different models of age-associated neurological disease. We singled out (a) ablation of NOS activity, and (b) synaptic bouton loss as key mechanisms by which TOR drives brain aging and contributes to the pathogenesis of dementias modeled in mice. Genetic and pharmacological inhibition of the mechanistic Target Of Rapamycin Complex 1 (mTORC1) promotes health and longevity in organisms ranging from yeast to mice, and may also have rejuvenative effects in dogs and humans. A potential barrier to the translation of rapamycin-based therapies to the clinic are the side effects of rapamycin, which include metabolic disruption. We and others have demonstrated that many of these side effects are mediated not by inhibition of mTORC1, but by "off-target" inhibition of a second mTOR complex, mTORC2. However, the effect of inhibiting mTORC2 on the healthspan and longevity of mammals has been largely unaddressed. Here, we will discuss our research exploring the contribution of mTORC2 signaling in three different tissues to the healthspan, metabolism, and longevity of mice. Senescent cells contribute to age-related pathology and loss of function, and their selective removal improves physiology and extends longevity. We have shown that deficiency in Nrf2 in young Nrf2KO mice leads to an increase in senescent cells, with increased levels of pro-inflammatory cytokines in various tissues, including the brain. Both the cellular senescence and SASP decrease significantly when these mice are treated with rapamycin. Our current work focuses on determining whether cellular senescence contributes to premature AD-like pathogenesis in mouse models of AD. Indeed, it has been shown that Nrf2 deficiency in mouse models for AD leads to exacerbated pathology, suggesting that increased inflammation, due in part to the increased SASP-producing senescent cells, might be contribute to this phenotype. We are testing whether the burden of senescent cells in the brain on mouse models of AD can be reverted by rapamycin. Previous studies reported that DR or low nutrient signaling reduces translation and extends lifespan, while attenuating growth and reproduction. In this study using C. elegans as a model organism, we found that reduced translation in neurons or germ tissues increases survival and primes the HSR against unfolded protein stress in adult animals. Surprisingly, lowering translation in these tissues significantly upregulates transcription of several key muscle maintenance genes, including those encoding the myogenic response factor HLH-1 and heavy myosin chain factor UNC-54 and MYO-3. It also improves muscle maintenance according to motility assays. However, reduced translation in muscle tissue does not activate the same level of myogenic gene expression. Instead, lowering translation in striated body muscle results in increased reproduction and accelerated development. To further investigate, we examined maintenance of muscle health via deconvolution fluorescent microscopy and immunostaining. Using computational analyses involving Fiji ImageJ and MATLAB program, we discovered that lowering translation delays decrepitude in body muscle structure, resulting in improved mitochondrial morphology and increased thermotolerance. Here we report that, combining physiological, molecular, and microscopic technique, muscle is protected during low translation, low TOR signaling, or DR. We hypothesize that results reflect evolutionary responses that preserve function required for foraging during nutrient scarcity and accelerate development during times low energy usage and high nutrient abundance.
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SEX AND TISSUE SPECIFIC ROLES OF MTORC2 IN HEALTHSPAN, METABOLISM, AND SURVIVAL
Dudley W. Lamming 1 , 1. University of Wisconsin-Madison, Madison, Wisconsin, United States Genetic and pharmacological inhibition of the mechanistic Target Of Rapamycin Complex 1 (mTORC1) promotes health and longevity in organisms ranging from yeast to mice, and may also have rejuvenative effects in dogs and humans. A potential barrier to the translation of rapamycin-based therapies to the clinic are the side effects of rapamycin, which include metabolic disruption. We and others have demonstrated that many of these side effects are mediated not by inhibition of mTORC1, but by "off-target" inhibition of a second mTOR complex, mTORC2. However, the effect of inhibiting mTORC2 on the healthspan and longevity of mammals has been largely unaddressed. Here, we will discuss our research exploring the contribution of mTORC2 signaling in three different tissues to the healthspan, metabolism, and longevity of mice.
ANTI-CELL SENESCENT EFFECTS OF RAPAMYCIN AND THEIR ROLE IN DISEASES, INCLUDING ALZHEIMER'S Viviana I. Perez 1 , 1. Linus Pauling Institute, Oregon State University, Corvallis, Oregon, United States
Senescent cells contribute to age-related pathology and loss of function, and their selective removal improves physiology and extends longevity. We have shown that deficiency in Nrf2 in young Nrf2KO mice leads to an increase in senescent cells, with increased levels of pro-inflammatory cytokines in various tissues, including the brain. Both the cellular senescence and SASP decrease significantly when these mice are treated with rapamycin. Our current work focuses on determining whether cellular senescence contributes to premature AD-like pathogenesis in mouse models of AD. Indeed, it has been shown that Nrf2 deficiency in mouse models for AD leads to exacerbated pathology, suggesting that increased inflammation, due in part to the increased SASP-producing senescent cells, might be contribute to this phenotype. We are testing whether the burden of senescent cells in the brain on mouse models of AD can be reverted by rapamycin. Previous studies reported that DR or low nutrient signaling reduces translation and extends lifespan, while attenuating growth and reproduction. In this study using C. elegans as a model organism, we found that reduced translation in neurons or germ tissues increases survival and primes the HSR against unfolded protein stress in adult animals. Surprisingly, lowering translation in these tissues significantly upregulates transcription of several key muscle maintenance genes, including those encoding the myogenic response factor HLH-1 and heavy myosin chain factor UNC-54 and MYO-3. It also improves muscle maintenance according to motility assays. However, reduced translation in muscle tissue does not activate the same level of myogenic gene expression. Instead, lowering translation in striated body muscle results in increased reproduction and accelerated development. To further investigate, we examined maintenance of muscle health via deconvolution fluorescent microscopy and immunostaining. Using computational analyses involving Fiji ImageJ and MATLAB program, we discovered that lowering translation delays decrepitude in body muscle structure, resulting in improved mitochondrial morphology and increased thermotolerance. Here we report that, combining physiological, molecular, and microscopic technique, muscle is protected during low translation, low TOR signaling, or DR. We hypothesize that results reflect evolutionary responses that preserve function required for foraging during nutrient scarcity and accelerate development during times low energy usage and high nutrient abundance.
LOW TRANSLATION DOWNSTREAM OF TOR ACTIVATES MYOGENE EXPRESSION AND ENHANCES

SESSION 1525 (SYMPOSIUM)
TECHNOLOGY-BASED HOME MONITORING TO ASSESS AND IMPROVE THE HEALTH AND WELL-BEING OF OLDER ADULTS
Chair: Walter R. Boot, Florida State University, Tallahassee, Florida, United States Technology, including in-home sensors, monitoring systems, and wearables, holds great promise with respect to being able to help manage chronic conditions, improve older adults' health, support their safety, prolong independence, and collect data for healthcare and research purposes. This symposium will introduce novel ways in which these systems are being deployed, and also important challenges to their implementation that could decrease their potential benefits. This technology will only be successful if it addresses key issues of adherence and privacy, and considers users' preferences. The first talk in this session will explore the novel use of GPS-based wearable sensors to capture the concept of life-space mobility, a measure critically related to quality of life and independence. The next talk focuses on a mobile health cardiovascular system and smartphone application, and finds that such systems can successfully transmit meaningful mHealth data while maintaining reasonable protocol adherence. Next, issues of user preference are discussed, including the types of data older adults and their children are willing to share, and the tradeoffs between values of privacy 370 Innovation in Aging, 2019, Vol. 3, No. S1 
